Clinical Trials Logo

Clinical Trial Summary

LSG is thought to be the best choice for obese patients with conincidental GISTs, as a tumour can be resected along with resecting the stomach within the same procedure. The primary endpoint is that, how much does GIST suppose to be far from a staple line to do safe laparoscopic sleeve gastrectomy


Clinical Trial Description

The incidence of unsuspected GIST in LSG specimens in our series was high in comparison to cases reported in the literature.

GISTs could be safely removed laparoscopically during LSG surgery with negative microscopic resection margins, with 1-2cm safety margin. Margins less than 1cm, high mitotic rate are adverse prognostic factors.

Examining the whole stomach before resection is mandatory and can easily be done during LSG, GIST can be removed safely with LSG ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04344847
Study type Interventional
Source Zagazig University
Contact
Status Recruiting
Phase N/A
Start date December 12, 2016
Completion date June 12, 2020

See also
  Status Clinical Trial Phase
Completed NCT04918381 - CellFX Treat & Resect Low-Risk BCC Feasibility Study N/A